BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 36734707)

  • 1. Dimethyl fumarate attenuates MSU-induced gouty arthritis by inhibiting NLRP3 inflammasome activation and oxidative stress.
    Cao Y; Hu Y; Jin XF; Liu Y; Zou JM
    Eur Rev Med Pharmacol Sci; 2023 Jan; 27(2):628-641. PubMed ID: 36734707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin ameliorates monosodium urate-induced gouty arthritis through Nod-like receptor 3 inflammasome mediation via inhibiting nuclear factor-kappa B signaling.
    Li X; Xu DQ; Sun DY; Zhang T; He X; Xiao DM
    J Cell Biochem; 2019 Apr; 120(4):6718-6728. PubMed ID: 30592318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetrahydropalmatine attenuates MSU crystal-induced gouty arthritis by inhibiting ROS-mediated NLRP3 inflammasome activation.
    Wang Y; Zhu W; Lu D; Zhang C; Wang Y
    Int Immunopharmacol; 2021 Nov; 100():108107. PubMed ID: 34482265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Palmatine Protects Against MSU-Induced Gouty Arthritis via Regulating the NF-κB/NLRP3 and Nrf2 Pathways.
    Cheng JJ; Ma XD; Ai GX; Yu QX; Chen XY; Yan F; Li YC; Xie JH; Su ZR; Xie QF
    Drug Des Devel Ther; 2022; 16():2119-2132. PubMed ID: 35812134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baeckein E suppressed NLRP3 inflammasome activation through inhibiting both the priming and assembly procedure: Implications for gout therapy.
    Lin X; Wang H; An X; Zhang J; Kuang J; Hou J; Yan M
    Phytomedicine; 2021 Apr; 84():153521. PubMed ID: 33667838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Celastrol ameliorates Propionibacterium acnes/LPS-induced liver damage and MSU-induced gouty arthritis via inhibiting K63 deubiquitination of NLRP3.
    Yan CY; Ouyang SH; Wang X; Wu YP; Sun WY; Duan WJ; Liang L; Luo X; Kurihara H; Li YF; He RR
    Phytomedicine; 2021 Jan; 80():153398. PubMed ID: 33130474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified Simiaowan prevents and treats gouty arthritis via the Nrf2/NLRP3 inflammasome signaling pathway.
    Qin DE; Liang W; Yu Y; Whelan EC; Yuan X; Wang ZL; Wu XW; Cao ZR; Hua SY; Yin L; Shi L; Liang T
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116906. PubMed ID: 37442492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of DaiTongXiao in the treatment of gouty arthritis through the NLRP3 signaling pathway.
    Liu F; Shen F; Bai Y; Wan Y; Zheng L; He J; Xie Y; Guo P
    J Ethnopharmacol; 2024 Jan; 319(Pt 3):117313. PubMed ID: 37924998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Protective Effects of Neoastilbin on Monosodium Urate Stimulated THP-1-Derived Macrophages and Gouty Arthritis in Mice through NF-κB and NLRP3 Inflammasome Pathways.
    Xu W; Li F; Zhang X; Wu C; Wang Y; Yao Y; Xia D
    Molecules; 2022 May; 27(11):. PubMed ID: 35684415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doliroside A attenuates monosodium urate crystals-induced inflammation by targeting NLRP3 inflammasome.
    Wei H; Hu C; Xie J; Yang C; Zhao Y; Guo Y; Mei Z; Chen L; Lan Z
    Eur J Pharmacol; 2014 Oct; 740():321-8. PubMed ID: 25064339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morin, a dietary bioflavonol suppresses monosodium urate crystal-induced inflammation in an animal model of acute gouty arthritis with reference to NLRP3 inflammasome, hypo-xanthine phospho-ribosyl transferase, and inflammatory mediators.
    Dhanasekar C; Rasool M
    Eur J Pharmacol; 2016 Sep; 786():116-127. PubMed ID: 27268719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NLRP3 inflammasome inhibitor cucurbitacin B suppresses gout arthritis in mice.
    Xue Y; Li R; Fang P; Ye ZQ; Zhao Y; Zhou Y; Zhang KQ; Li L
    J Mol Endocrinol; 2021 Jun; 67(2):27-40. PubMed ID: 34047713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Leflunomide Analog, UTLOH-4e, Ameliorates Gouty Arthritis Induced by Monosodium Urate
    Yuan T; Chen S; Yin Y; Shaw J; Zeng J; Li L; Song L; Zhang Y; Yin Z; Zhao J
    Curr Pharm Biotechnol; 2024; 25(3):350-364. PubMed ID: 37078349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hesperidin Methylchalcone Suppresses Experimental Gout Arthritis in Mice by Inhibiting NF-κB Activation.
    Ruiz-Miyazawa KW; Pinho-Ribeiro FA; Borghi SM; Staurengo-Ferrari L; Fattori V; Amaral FA; Teixeira MM; Alves-Filho JC; Cunha TM; Cunha FQ; Casagrande R; Verri WA
    J Agric Food Chem; 2018 Jun; 66(25):6269-6280. PubMed ID: 29852732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guizhi-Shaoyao-Zhimu decoction attenuates monosodium urate crystal-induced inflammation through inactivation of NF-κB and NLRP3 inflammasome.
    Zhou GQ; Chen G; Yang J; Qin WY; Ping J
    J Ethnopharmacol; 2022 Jan; 283():114707. PubMed ID: 34619319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Berberine on Activation of TLR4-NFκB Signaling Pathway and NLRP3 Inflammasome in Patients with Gout.
    Dang WT; Xu D; Zhou JG
    Chin J Integr Med; 2023 Jan; 29(1):10-18. PubMed ID: 36125615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cynarin suppresses gouty arthritis induced by monosodium urate crystals.
    Wu C; Chen S; Liu Y; Kong B; Yan W; Jiang T; Tian H; Liu Z; Shi Q; Wang Y; Liang Q; Xi X; Xu H
    Bioengineered; 2022 May; 13(5):11782-11793. PubMed ID: 35546047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gallic Acid Alleviates Gouty Arthritis by Inhibiting NLRP3 Inflammasome Activation and Pyroptosis Through Enhancing Nrf2 Signaling.
    Lin Y; Luo T; Weng A; Huang X; Yao Y; Fu Z; Li Y; Liu A; Li X; Chen D; Pan H
    Front Immunol; 2020; 11():580593. PubMed ID: 33365024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Gentiopicroside on activation of NLRP3 inflammasome in acute gouty arthritis mice induced by MSU.
    He M; Hu C; Chen M; Gao Q; Li L; Tian W
    J Nat Med; 2022 Jan; 76(1):178-187. PubMed ID: 34586567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gout-associated monosodium urate crystal-induced necrosis is independent of NLRP3 activity but can be suppressed by combined inhibitors for multiple signaling pathways.
    Zhong CS; Zeng B; Qiu JH; Xu LH; Zhong MY; Huang YT; Xu R; Liu SY; Zha QB; Hu B; Ou-Yang DY; He XH
    Acta Pharmacol Sin; 2022 May; 43(5):1324-1336. PubMed ID: 34376811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.